PMID: 2045363Jun 1, 1991Paper

The Escherichia coli hemL gene encodes glutamate 1-semialdehyde aminotransferase

Journal of Bacteriology
L L IlagD Söll

Abstract

delta-Aminolevulinic acid (ALA), the first committed precursor of porphyrin biosynthesis, is formed in Escherichia coli by the C5 pathway in a three-step, tRNA-dependent transformation from glutamate. The first two enzymes of this pathway, glutamyl-tRNA synthetase and Glu-tRNA reductase, are known in E. coli (J. Lapointe and D. Söll, J. Biol. Chem. 247:4966-4974, 1972; D. Jahn, U. Michelsen, and D. Söll, J. Biol. Chem. 266:2542-2548, 1991). Here we present the mapping and cloning of the gene for the third enzyme, glutamate 1-semialdehyde (GSA) aminotransferase, and an initial characterization of the purified enzyme. Ethylmethane sulfonate-induced mutants of E. coli AB354 which required ALA for growth were isolated by selection for respiration-defective strains resistant to the aminoglycoside antibiotic kanamycin. Two mutations were mapped to min 4 at a locus named hemL. Map positions and resulting phenotypes suggest that hemL may be identical with the earlier described porphyrin biosynthesis mutation popC. Complementation of the auxotrophic phenotype by wild-type DNA from the corresponding clone pLC4-43 of the Clarke-Carbon bank (L. Clarke and J. Carbon, Cell 9:91-99, 1976) allowed the isolation of the gene. Physical mapping sh...Continue Reading

References

Jun 1, 1990·Microbiological Reviews·B J Bachmann
Jan 1, 1990·Methods in Enzymology·F W StudierJ W Dubendorff
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B Grimm
Apr 1, 1989·Molecular & General Genetics : MGG·T Elliott, J R Roth
Jan 1, 1973·Enzyme·K A PowellH P Charles
Jul 1, 1980·Journal of Bacteriology·R J KadnerV Braun
Jun 5, 1983·Journal of Molecular Biology·D Hanahan

❮ Previous
Next ❯

Citations

Dec 12, 2012·Science·Abu Amar M Al MamunSusan M Rosenberg
Oct 16, 1999·The Journal of Biological Chemistry·J MoserD Jahn
Aug 21, 1995·Molecular & General Genetics : MGG·C HungererD Jahn
Nov 19, 2015·Microbial Cell Factories·Xiaoli YuQingsheng Qi
Mar 14, 2019·Frontiers in Molecular Biosciences·Caterina NardellaRoberto Contestabile
Sep 4, 2001·Biotechnology & Genetic Engineering Reviews·S Nishikawa, Y Murooka
Oct 9, 2002·The Journal of Biological Chemistry·Stefan SchauerDieter Jahn
Jun 15, 1993·European Journal of Biochemistry·I Weygand-DurasevićD Söll
Jun 15, 2004·The Journal of Biological Chemistry·Lennart RandauDieter Jahn
Jun 1, 1995·Photosynthesis Research·Y J Avissar, P A Moberg
Dec 13, 2005·Eukaryotic Cell·Ariane AtteiaSamuel I Beale
Jul 22, 2008·Journal of Bacteriology·Ryoko Tatsumi, Masaaki Wachi
Nov 11, 1996·Biochimica Et Biophysica Acta·W ChenS Lee
Aug 27, 1992·Biochimica Et Biophysica Acta·P MacherouxV Massey
Jun 1, 1992·Trends in Biochemical Sciences·D JahnD Söll
Sep 1, 2008·EcoSal Plus·Jorge C Escalante-Semerena, Martin J Warren
Apr 1, 2007·EcoSal Plus·Samuel I Beale
Sep 8, 1998·Microbiology and Molecular Biology Reviews : MMBR·M K Berlyn
Mar 28, 2006·Journal of Molecular Biology·Jörg O SchulzeDirk W Heinz
Dec 1, 1993·Microbiological Reviews·M Riley
May 26, 2009·International Journal for Parasitology·Fiona L HenriquezCraig W Roberts

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.